4-Bromo-3-chlorotoluene | CAS:6627-51-6

We serve 4-Bromo-3-chlorotoluene CAS:6627-51-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromo-3-chlorotoluene

Chemical Name:4-Bromo-3-chlorotoluene
CAS.NO:6627-51-6
Synonyms:4-Bromo-3-chlorotoluene
1-Bromo-2-chloro-4-methylbenzene
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 232.1±20.0 °C at 760 mmHg
Molecular Formula C7H6BrCl
Molecular Weight 205.480
Flash Point 105.8±11.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.566
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Bromo-3-chlorotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Bromo-2-chloro-4-methylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-3-chlorotoluene Use and application,1-Bromo-2-chloro-4-methylbenzene technical grade,usp/ep/jp grade.


Related News: Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.”N-(3-chloro-4-fluorophenyl)-7-(3-morpholin-4-ylpropoxy)-6-nitroquinazolin-4-amine manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.2-Amino-6-methylheptane hydrochloride supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.(3R)-1-azabicyclo[2.2.2]octan-3-ol vendor According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.